ZA200902475B - HCV NS3 Protease Inhibitors - Google Patents
HCV NS3 Protease InhibitorsInfo
- Publication number
- ZA200902475B ZA200902475B ZA200902475A ZA200902475A ZA200902475B ZA 200902475 B ZA200902475 B ZA 200902475B ZA 200902475 A ZA200902475 A ZA 200902475A ZA 200902475 A ZA200902475 A ZA 200902475A ZA 200902475 B ZA200902475 B ZA 200902475B
- Authority
- ZA
- South Africa
- Prior art keywords
- hcv
- protease inhibitors
- protease
- inhibitors
- Prior art date
Links
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US85491206P | 2006-10-27 | 2006-10-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200902475B true ZA200902475B (en) | 2010-03-31 |
Family
ID=41484197
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200902475A ZA200902475B (en) | 2006-10-27 | 2009-04-09 | HCV NS3 Protease Inhibitors |
Country Status (3)
Country | Link |
---|---|
CN (1) | CN101611039A (en) |
UA (1) | UA95990C2 (en) |
ZA (1) | ZA200902475B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9624245B2 (en) * | 2013-02-07 | 2017-04-18 | Bristol-Myers Squibb Company | Macrocyclic compounds as HCV entry inhibitors |
EP2964655B1 (en) * | 2013-03-07 | 2018-04-25 | Bristol-Myers Squibb Company | Macrocyclic compounds for the treatment of hepatitis c |
CN108368130B (en) * | 2016-05-16 | 2021-03-02 | 深圳市塔吉瑞生物医药有限公司 | Substituted macrocyclic quinoxaline compound, pharmaceutical composition and application thereof |
-
2007
- 2007-10-23 UA UAA200905267A patent/UA95990C2/en unknown
- 2007-10-23 CN CNA2007800486662A patent/CN101611039A/en active Pending
-
2009
- 2009-04-09 ZA ZA200902475A patent/ZA200902475B/en unknown
Also Published As
Publication number | Publication date |
---|---|
UA95990C2 (en) | 2011-09-26 |
CN101611039A (en) | 2009-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL198401A0 (en) | Hcv ns3 protease inhibitors | |
EP2083844A4 (en) | Hcv ns3 protease inhibitors | |
EP2079480A4 (en) | Hcv ns3 protease inhibitors | |
EP2079479A4 (en) | Hcv ns3 protease inhibitors | |
EP2076278A4 (en) | Hcv ns3 protease inhibitors | |
HK1121169A1 (en) | Hcv ns3 protease inhibitors hcv ns3 | |
EP1879607A4 (en) | Hcv ns3 protease inhibitors | |
EP2271345A4 (en) | Hcv ns3 protease inhibitors | |
HK1210142A1 (en) | Hcv protease inhibitors and uses thereof hcv | |
HK1210141A1 (en) | Hcv protease inhibitors and uses thereof hcv | |
EP1906945A4 (en) | Hcv inhibitors | |
IL189166A0 (en) | Macrocyclic peptides as hcv ns3 protease inhibitors | |
EP2125870A4 (en) | Inhibitors of hepatitis c ns3 protease | |
IL195515A0 (en) | Macrocyclic oximyl hepatitis c protease inhibitors | |
TWI367211B (en) | Hcv ns-3 serine protease inhibitors | |
HK1148739A1 (en) | Hcv protease inhibitors hcv | |
ZA200709987B (en) | Combination of HCV protease inhibitors with a surfactant | |
BRPI0923184A2 (en) | hcv ns3 protease inhibitors | |
IL182339A0 (en) | Hcv ns3-ns4a protease inhibition | |
EP2432318A4 (en) | Bimacrocyclic hcv ns3 protease inhibitors | |
ZA200800072B (en) | HCV NS3 Protease inhibitors | |
EP2064177A4 (en) | Protease inhibitors | |
ZA200902475B (en) | HCV NS3 Protease Inhibitors | |
ZA200800507B (en) | Macrocyclic peptides as HCV NS3 protease inhibitors | |
ZA200711069B (en) | HCV inhibitors |